A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

Clinical trial NCT06682117 · RECRUITING

Trial details

NCT number: NCT06682117
Sponsor: Fudan University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Treatment Neoantigen Vaccine Solid Tumor Cancer

Start date: 2024-11-15
Primary completion: 2026-12-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.